Recent trends in use of adjuvant chemotherapy in elderly stage II–III non-small cell lung cancer

BACKGROUND: Although randomized trials demonstrated survival benefit of adjuvant chemotherapy, previous reports have suggested that its use in elderly populations for early stage non-small cell lung cancer (NSCLC) was infrequent. The current status of adjuvant chemotherapy in this population is unkn...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiya, Takefumi, Powell, Emily, Guddati, Achuta Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481576/
https://www.ncbi.nlm.nih.gov/pubmed/32953496
http://dx.doi.org/10.21037/tlcr-19-564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481576/
https://www.ncbi.nlm.nih.gov/pubmed/32953496
http://dx.doi.org/10.21037/tlcr-19-564

Ejemplares similares